IN2014CH01890A - - Google Patents

Download PDF

Info

Publication number
IN2014CH01890A
IN2014CH01890A IN1890CH2014A IN2014CH01890A IN 2014CH01890 A IN2014CH01890 A IN 2014CH01890A IN 1890CH2014 A IN1890CH2014 A IN 1890CH2014A IN 2014CH01890 A IN2014CH01890 A IN 2014CH01890A
Authority
IN
India
Prior art keywords
sterile formulation
preparation
same
sterile
formulation
Prior art date
Application number
Other languages
English (en)
Inventor
Arvind Gannimitta
Sachin Jain
Sagar Rase
Jayant Karajgi
Sivakumaran Meenakshisunderam
Original Assignee
Aurobindo Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd filed Critical Aurobindo Pharma Ltd
Priority to IN1890CH2014 priority Critical patent/IN2014CH01890A/en
Priority to US14/683,105 priority patent/US20150290220A1/en
Publication of IN2014CH01890A publication Critical patent/IN2014CH01890A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1890CH2014 2014-04-10 2014-04-10 IN2014CH01890A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1890CH2014 IN2014CH01890A (de) 2014-04-10 2014-04-10
US14/683,105 US20150290220A1 (en) 2014-04-10 2015-04-09 Pharmaceutical formualtions comprising a Gluococorticosteroid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1890CH2014 IN2014CH01890A (de) 2014-04-10 2014-04-10

Publications (1)

Publication Number Publication Date
IN2014CH01890A true IN2014CH01890A (de) 2015-10-16

Family

ID=54264158

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1890CH2014 IN2014CH01890A (de) 2014-04-10 2014-04-10

Country Status (2)

Country Link
US (1) US20150290220A1 (de)
IN (1) IN2014CH01890A (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1476201T3 (da) * 2002-02-19 2009-03-30 Resolution Chemicals Ltd Solvent-baseret sterilisering af steroider
DE10214002A1 (de) * 2002-03-27 2003-10-09 Roehm Gmbh Pharmazeutische Formulierung für den Wirkstoff Budesonid
GB0425266D0 (en) * 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process

Also Published As

Publication number Publication date
US20150290220A1 (en) 2015-10-15

Similar Documents

Publication Publication Date Title
ZA202004557B (en) Modulatory polynucleotides
EP4620519A3 (de) Verfahren und zusammensetzungen im zusammenhang mit chondrisomen aus blutprodukten
WO2015117081A3 (en) Methods and compositions for treatment of a beta thalessemia
EP3800248A3 (de) Crispr-cas-assoziierte verfahren, zusammensetzungen und komponenten für krebsimmuntherapie
MY192927A (en) Fused bicyclic compounds for the treatment of disease
EP3179993A4 (de) Verfahren zur behandlung von depression
MX2017008456A (es) Compuestos biciclicos fusionados para el tratamiento de enfermedades.
PH12017500239A1 (en) Abiraterone acetate formulation and methods of use
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
EP3166931A4 (de) Verbessertes verfahren zur herstellung von exametazim
EP3280408A4 (de) Verfahren zur herstellung von dicycloplatin
ZA201703467B (en) Methods of treating ocular conditions
IN2014CH00840A (de)
EP3174991A4 (de) Verfahren, zusammensetzungen und kits zur analyse von strukturell unterschiedlichen komplexen lipiden
EP3227298A4 (de) Verfahren zur herstellung von baricitinib und zwischenprodukten davon
EP3169405A4 (de) Verfahren, verbindungen und zusammensetzungen zur behandlung von muskelskeletterkrankungen
EP3148540A4 (de) Verfahren zur herstellung von cyclischen depsipeptiden
SG10201908248PA (en) Processes for preparing fluoroketolides
HK1255221A1 (zh) 使用卡多曲组合物进行治疗的方法
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
EP3386944A4 (de) Verfahren zur herstellung von lisdexamphetamin
NZ721832A (en) Solid forms of tenofovir
IL249297A0 (en) Devices and kits to create personal, concentrated compounds of human milk, and methods for their preparation and use
EP3303345A4 (de) Ertugliflozin-cokristalle und verfahren zu deren herstellung
EP3142999A4 (de) Verfahren und zusammensetzungen aus dasotralin zur behandlung von adhd